FDA Clearance Tracker · P940015
SYNVISC ONE
Last checked: Nov 20, 2026Latest source record: Aug 8, 1997 (this decision)Source: openFDAMethods & limitations
Decided
Aug 8, 1997
Approved
Time to decision
1,165 days
Received May 31, 1994. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P940015
- Device name
- SYNVISC ONE
- Applicant
- Sanofi Genzyme Corp.
- Applicant location
- Cambridge, MA
- Received
- May 31, 1994
- Decided
- Aug 8, 1997
- Decision
- Approved
- Supplements
- 51 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Acid, hyaluronic, intraarticular (MOZ)
- Device class
- Class III
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
APPROVAL FOR SYNVISC(R) HYLAN G-F 20. THIS DEVICE IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS (OA) OF THE KNEE IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TO CONSERVATIVE NONPHARMACOLOGIC THERAPY AND TO SIMPLE ANALGESICS, E.G., ACETAMINOPHEN.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MOZ. The earliest in FDA's data is P950027, decided May 28, 1997.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Sanofi Genzyme Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.